UTI Liquid Fund - Direct Plan - Annual IDCW

UTI Liquid Fund - Direct Plan - Annual IDCW holds up reasonably well within the Liquid category, currently carrying a 3-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 69/100.

Cost: At 0.17%, the expense ratio runs 13% above the Liquid category average of 0.15%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -1.12 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, with 79.27% annualised volatility, this is among the more turbulent funds in its space — expect sharp swings in both directions.

Who should invest: This fund is best suited to conservative investors prioritising capital stability and predictable income over high growth.